选择语言

Human IL-11 R alpha (Luc) HEK293 Reporter Cell

用户评价
货号-规格
价格
Qty.
CHEK-ATF052-2Vials (1Vial X 2)
询价
合计0件 产品金额¥ 0

产品详情

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • 描述(Description)

    The Human IL-11 R alpha (Luc) HEK293 Reporter Cell was engineered to express STAT3 signaling response element. When stimulated with human IL-11 protein, the IL-11/ IL-11 R alpha interaction drives STAT3-mediated luminescence. Inhibition of IL-11 binding to IL-11 R alpha by either anti-IL-11 or anti-IL-11 R alpha antibodies results in a decrease in luminescence.

  • 应用说明(Application)

    • Screen for anti-human IL-11 or anti-human IL-11 R alpha neutralizing antibody.

    IL-11 R alpha Assay Principles

  • 生长特性(Growth Properties)

    Adherent

  • 筛选标记(Selection Marker)

    Hygromycin B (40 μg/mL)

  • 培养基(Complete Growth Medium)

    DMEM medium + 10% FBS

  • 冻存液(Freeze Medium)

    Serum-free cell cryopreservation medium

  • 装量(Quantity)

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • 存储(Storage)

    Frozen in liquid nitrogen.

  • 支原体检测(Mycoplasma Testing)

    Negative

  • 无菌检测(Sterility Testing)

    Negative

  • 使用说明(Instructions for Use)

    See data sheet for detailed culturing and assay protocol.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • Application

     IL-11 R alpha APPLICATION

    Inhibition of human IL-11 protein-induced reporter activity by anti-human IL-11 neutralizing antibody.
    This reporter cell was incubated with serial dilutions of antibodies in the presence of human IL-11 protein (Cat. No. IL1-H5243) with a final concentration of 0.2 μg/mL. The EC50 of anti-human IL-11 neutralizing antibody is approximately 1.047 μg/mL.

    Protocol
  • Signaling Bioassay

     IL-11 R alpha SIGNALING

    Response to human IL-11 protein (RLU).
    The Human IL-11 R alpha (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-11 protein (Cat. No. IL1-H5243). The EC50 was approximately 0.12 μg/mL.

    Protocol
  •  IL-11 R alpha SIGNALING

    Response to human IL-11 protein (FOLD).
    The Human IL-11 R alpha (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-11 protein (Cat. No. IL1-H5243). The max induction fold was approximately 31.

    Protocol
*如有相关细胞池需求请联系我们

用户评价
发表评论

背景介绍

IL-11 and IL-6 are signal transducer and activator of transcription 3 (STAT3) activators and frequently found upregulated in colorectal cancer (CRC). STAT3 activation in tumor epithelial cells is critically involved in the pathogenesis of CRC. Cancer-associated fibroblasts (CAFs) can modulate the tumor microenvironment in CRC. The latest research indicated that phosphorylation of STAT3 (pSTAT3) expression in CAFs is inversely correlated with the survival in CRC patients. IL-6 and IL-11 induce partly overlapping gene expression patterns in fibroblast subsets in CRC. In a summary, STAT3 activation in CAFs plays a key role in the cross-talk to the tumor epithelium.

重要声明

  • Limited Use&License Disclosure

    BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.

    1. If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
    2. Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
    3. This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use. You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    4. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    5. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    6. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order.cn@acrobiosystems.com for further details.

前沿进展

 
药物研发进展
  • 英文全称:

    Interleukin 11 receptor alpha

  • 中文全称:

    白细胞介素-11受体α

  • 种类:

  • 上市药物数量:

    9 详情

  • 临床药物数量:

    3 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价
  • 背景介绍
  • 重要声明